These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 4888435)

  • 1. [On stabilization of the immunogenic properties of plague strain EB vaccine by the animalization method].
    Priadkina MD; Zhurba MD
    Zh Mikrobiol Epidemiol Immunobiol; 1966 Oct; 43(10):16-20. PubMed ID: 4888435
    [No Abstract]   [Full Text] [Related]  

  • 2. [THE INVASIVE CAPACITY OF AVIRULENT PLAGUE BACILLUS CULTURES].
    FAIBICH MM
    Zh Mikrobiol Epidemiol Immunobiol; 1964 May; 41():36-41. PubMed ID: 14231864
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunogenicity of plague vaccines in mice and guinea pigs.
    von Metz E; Eisler DM; Hottle GA
    Appl Microbiol; 1971 Jul; 22(1):84-8. PubMed ID: 5111306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plague immunization. VI. Vaccination with the fraction I antigen of Yersinia pestis.
    Meyer KF; Hightower JA; McCrumb FR
    J Infect Dis; 1974 May; 129():Suppl:S41-5. PubMed ID: 4825248
    [No Abstract]   [Full Text] [Related]  

  • 5. Live, attenuated Yersinia pestis vaccine: virulent in nonhuman primates, harmless to guinea pigs.
    Meyer KF; Smith G; Foster L; Brookman M; Sung M
    J Infect Dis; 1974 May; 129():Suppl:S85-12. PubMed ID: 4207627
    [No Abstract]   [Full Text] [Related]  

  • 6. [The possibility of using automated morphometry for assessing the functional status of the microbial cells during stab cultivation in the production of plague vaccine].
    Cherniad'ev AV; Zolotareva AG; Slavianskiĭ VM; Dodonov NP; Chicherin IuV
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (6):3-4. PubMed ID: 8079544
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of nutrients and temperature in the growth of P.pestis for vaccine production. II. The role of Ca++ and Mg++ in plague vaccine production.
    Gadgil MD; Nimbkar YS; Jhala HI
    Indian J Pathol Bacteriol; 1967 Jul; 10(3):245-54. PubMed ID: 4862883
    [No Abstract]   [Full Text] [Related]  

  • 8. A Yersinia pestis lpxM-mutant live vaccine induces enhanced immunity against bubonic plague in mice and guinea pigs.
    Feodorova VA; Pan'kina LN; Savostina EP; Sayapina LV; Motin VL; Dentovskaya SV; Shaikhutdinova RZ; Ivanov SA; Lindner B; Kondakova AN; Bystrova OV; Kocharova NA; Senchenkova SN; Holst O; Pier GB; Knirel YA; Anisimov AP
    Vaccine; 2007 Nov; 25(44):7620-8. PubMed ID: 17913308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Electrophoretic mobility and energy charge of the adenyl system of blood lymphocytes in guinea pigs immunized against plague with strain Yersinia pestis ev subcultures with different immunogenicity].
    Anisimova TI; Saiapina LV; Korsukov VN
    Zh Mikrobiol Epidemiol Immunobiol; 2005; (5):63-6. PubMed ID: 16279538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Survival of EB microbes in live plague vaccine and its immunogeneity in the process of prolonged storage].
    Chicherin IuV; Lebedinskiĭ VA; Evstigneev VI
    Zh Mikrobiol Epidemiol Immunobiol; 1977 Aug; (8):139-40. PubMed ID: 919933
    [No Abstract]   [Full Text] [Related]  

  • 11. Assessment of Live Plague Vaccine Candidates.
    Feodorova VA; Sayapina LV; Motin VL
    Methods Mol Biol; 2016; 1403():487-98. PubMed ID: 27076149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study in mice of the protective power of the EV strain of Yersinia pestis and of its culture supernatant].
    Fournier JM; Creach O; Chaboud JJ; Dodin A; Fontanges R
    C R Acad Hebd Seances Acad Sci D; 1972 Dec; 275(25):3057-9. PubMed ID: 4631979
    [No Abstract]   [Full Text] [Related]  

  • 13. [Morphological structure of Yersinia pestis populations (strain EV) in the process of live plague vaccine production].
    Cherniad'ev AV
    Zh Mikrobiol Epidemiol Immunobiol; 2004; (6):43-7. PubMed ID: 15636139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral vaccination against plague using Yersinia pseudotuberculosis.
    Demeure CE; Derbise A; Carniel E
    Chem Biol Interact; 2017 Apr; 267():89-95. PubMed ID: 27046452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The modifying action of normal human blood serum on vaccinal EV76 and virulent 363(1/1479) strains of Yersinia pestis].
    Ziuzina VP; Tynianova VI; Kravtsov AN; Khodova VA
    Mikrobiol Zh (1978); 1988; 50(5):87-92. PubMed ID: 3249590
    [No Abstract]   [Full Text] [Related]  

  • 16. [Construction of variants of Yersinia pestis EV76 (RIEG line) vaccine strain differing in antibiotic resistance spectra with stage-by-stage transduction of R-transposons].
    Cherniavskaia AS; Morozova IV; Lebedeva SA; Zarenkov MI
    Antibiot Khimioter; 2005; 50(7):13-7. PubMed ID: 16768208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Morphofunctional evaluation of the state of cells of APUD-system biomodel during anti-plague vaccine process].
    Bugorkova SA; Kutyreva VV
    Zh Mikrobiol Epidemiol Immunobiol; 2013; (4):49-55. PubMed ID: 24341215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In vitro selection of P. pestis variants with vaccinal properties].
    Akimovich VV; Nikoaev II; Zykin LF; Ponomarev NG; Popov AA
    Zh Mikrobiol Epidemiol Immunobiol; 1965 Jun; 42(6):64-8. PubMed ID: 5870008
    [No Abstract]   [Full Text] [Related]  

  • 19. [On the variability of the plague vaccinal strain EB].
    Zhurba MD; Priadkina MD; Abramova GF
    Zh Mikrobiol Epidemiol Immunobiol; 1966 Apr; 43(4):64-7. PubMed ID: 6004746
    [No Abstract]   [Full Text] [Related]  

  • 20. [Lectin of Yersinia pestis vaccine strain EV and its immunological properties].
    Tikhomirova EI; Zadnova SP; Volokh OA; Karpunina LV; Shcherbakov AA
    Zh Mikrobiol Epidemiol Immunobiol; 2003; (1):51-5. PubMed ID: 12630354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.